Precision BioSciences
DTIL
95 hedge funds and large institutions have $387M invested in Precision BioSciences in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 37 increasing their positions, 11 reducing their positions, and 10 closing their positions.
236% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 11
230% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 10
117% more capital invested
Capital invested by funds: $179M → $387M (+$208M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
32% more funds holding
Funds holding: 72 → 95 (+23)
0.43% more ownership
Funds ownership: 1.4% → 1.83% (+0.43%)
48% less call options, than puts
Call options by funds: $523K | Put options by funds: $997K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$36M |
| 2 |
BlackRock
New York
|
+$20.5M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$15.8M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$8.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$15.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.6M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.34M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$6.25M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$5.68M |
DTIL Hedge Fund Activity: Q4 2019 in Review
95 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2019, worth a combined $387M — up 117% from $179M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new DTIL positions and 10 closed out — a net gain of 23 holders — while 37 added to existing stakes and 11 trimmed.
The largest buyer was Capital World Investors, adding an estimated $36M. The largest seller was RA Capital Management, exiting entirely with an estimated $15.5M sold.
- 95 institutional investors held Precision BioSciences (DTIL) as of Q4 2019, up from 72 in Q3 2019.
- Funds reported $387M of Precision BioSciences stock for Q4 2019, up 117% quarter-over-quarter.
- 33 funds opened new Precision BioSciences positions in Q4 2019 and 10 closed out, a net change of +23 holders.
- The largest Precision BioSciences buyer in Q4 2019 was Capital World Investors, an estimated $36M added.
- The largest Precision BioSciences seller in Q4 2019 was RA Capital Management, an estimated $15.5M sold.
Based on aggregated 13F filings for Q4 2019.